carbidopa

January 29, 2019January 31, 2019

Levodopa Shows No Disease-modifying Effects in Parkinson’s, Study Finds

News

Levodopa/carbidopa treatment is effective in managing Parkinson’s motor symptoms, but does not protect against disease progression among patients with early disease, a study shows. The research, “Randomized Delayed-Start Trial of ... Read more

January 24, 2019January 31, 2019

Gut Bacteria Affect Metabolism of Parkinson’s Therapy Levodopa, Study Shows

News

Levodopa, one of the main medicines used to treat Parkinson’s symptoms, can be converted into dopamine by gut bacteria, researchers report. The findings might explain why levodopa treatment is ... Read more

December 3, 2018December 7, 2018

Xadago as Add-on Treatment for Parkinson’s Now Approved in Australia

News

Xadago (safinamide) has been approved in Australia as an add-on therapy to a treatment regimen that includes levodopa for adults with idiopathic (no genetic or other known cause) Parkinson’s disease. This decision ... Read more

October 6, 2017October 6, 2017

Carbidopa Reduced Tumor Growth in Lab Studies of Cancer

News

Carbidopa, a medicine approved for the treatment of Parkinson’s disease, also has shown anti-cancer effects in lab-grown human cells and mice, according to the results of a new study. ... Read more

October 18, 2016

New Therapy for Parkinson’s ‘Off’ Periods Shows Promising Results in Preclinical Studies

News

CVT-301, an inhalable drug under development by Acorda Therapeutics to treat Parkinson’s symptoms during “off” periods when currently available drugs don’t adequately work, showed promising results in preclinical Phase 1 and 2 ... Read more

March 21, 2016March 21, 2016

CONy16: AbbVie’s DUOPA Pump Continues to Show Efficacy as Parkinson’s Treatment; Exclusive Interview with a Lead Researcher

News

Multinational research-based biopharmaceutical company AbbVie‘s product DUOPA is a fresh approach to the administration of carbidopa and levodopa for the treatment of motor fluctuations that afflict people with advanced ... Read more

October 19, 2015October 19, 2015

Stable Parkinson’s Disease Drug Therapy Status Quo Could Soon Be Disrupted by New Category Entrants

News

Burlington, Massachusetts-based, medical market research firm Decision Resources Group (DRG) reports, citing analyses of U.S. longitudinal patient-level claims data, that the Parkinson’s disease (PD) drug treatment algorithm remains highly ... Read more

Pin It on Pinterest